Stephen Clarke COSA-IPOS Joint Scientific Meeting 2012

Abstracts this author is presenting:

• An Australian translational study to evaluate the prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab (Avastin^TM) [ASCENT] — COSA Posters: Clinical Research